Sep 07, 2022
Size exclusion chromatography of cell lysates containing Tau aggregates
- Patricia Yuste Checa1,
- Itika Saha1,
- F. Ulrich Hartl1,
- Mark S. Hipp2,3
- 1Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany;
- 2Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan, 1, 9713 AV Groningen, The Netherlands;
- 3School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany
Protocol Citation: Patricia Yuste Checa, Itika Saha, F. Ulrich Hartl, Mark S. Hipp 2022. Size exclusion chromatography of cell lysates containing Tau aggregates. protocols.io https://dx.doi.org/10.17504/protocols.io.4r3l27mjpg1y/v1
Manuscript citation:
The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds Itika Saha, Patricia Yuste-Checa, Miguel Da Silva Padilha, Qiang Guo, Roman Körner, Hauke Holthusen, Victoria A. Trinkaus, Irina Dudanova, Rubén Fernández-Busnadiego, Wolfgang Baumeister, David W. Sanders, Saurabh Gautam, Marc I. Diamond, F. Ulrich Hartl, Mark S. Hipp bioRxiv 2022.02.18.481043; doi: https://doi.org/10.1101/2022.02.18.481043
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: September 06, 2022
Last Modified: June 01, 2024
Protocol Integer ID: 69591
Keywords: ASAPCRN, tau aggregates from cell lysate, containing tau aggregate, tau aggregates this protocolcan, size exclusion chromatography of cell lysate, tau aggregate, aggregates of tau repeat domain, size exclusion chromatography, using hek293 cell, tau repeat domain, hek293 cell, mutations p301l, related mutations p301l, cell lysate
Abstract
This protocolcan be used to fractionate Tau aggregates from cell lysates by size exclusion chromatography. The protocol was optimized using HEK293 cells stably expressing and propagating aggregates of Tau repeat domain, containing the disease-related mutations P301L and V337M, fused to YFP (Clone 10 from Sanders et al., Neuron, 2014). However, any cell line containing Tau aggregates can be used.
Troubleshooting
Lyse cell pellets with Triton buffer, Complete EDTA-free protease inhibitor cocktail (Roche) and benzonase for 20 min on ice. NOTE: Triton buffer: 0.05% Triton X-100/PBS or 1% Triton X-100/PBS (more efficient lysis) can be used to lyse cell pellets.
30m
Clarify the lysates by centrifugation at 1,000 x g for 5 min at 4 °C and filter the supernatant with a PVDF 0.22 μm filter (Millex, #SLGVX13NL).
5m
Quantify total protein by Bio-Rad Protein Assay (Bio-Rad) or Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
Load 3 mg total protein on a Superose 6 HR10/30 (GE 875 Healthcare) column previously equilibrated with PBS.
NOTES: Cells from a confluent T75 flask lysed with 800 µL lysis buffer results in ~ 8-10 mg/mL total protein. Superose 6 HR10/30 (GE Healthcare): Flow rate 0.5 mL/min; 1mL fractions up to void volume of the column and 0.5 mL fractions from void volume to the end.
Analyze and quantify individual fractions by Western blot. NOTES: Use 15 µl of each fraction to detect TauRD-YFP by immunoblotting with anti-GFP antibody (Roche #11814460001).
High molecular weight (HMW) species are detected in the void volume of the column while low molecular weight (LMW) species are detected around 15 mLelution volume (fractions ~24-27). TauRD-YFP cleaved products are detected along with TauRD-YFP in the LMW fractions.
The corresponding fractions, HMW and LMW species, can be pooled and quantified (using purified TauRD-YFP as standard) by immunoblotting to perform other biochemical assays or cell-based Tau seeding assays.
Note
NOTE: Seeding with 0.5 ng HMW species from TauRD-YFP Clone 10 results in ~20% FRET positive cells while 0.5 ng LMW species results in ~1-2% FRET positive cells following the protocol “Cell-based Tau seeding assay” (Yuste-Checa et al., Nature Communication, 2021).